Pharmacotherapy

Papers
(The TQCC of Pharmacotherapy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management83
A guide to therapeutic drug monitoring of β‐lactam antibiotics70
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐1956
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the I53
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents43
Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective39
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review33
Drug‐Induced Ototoxicity: A Comprehensive Review and Reference Guide31
Meta‐analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD31
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens30
Gut microbiome health and dysbiosis: A clinical primer30
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?29
Optimizing anticoagulation for patients receiving Impella support27
CBD and THC: Do They Complement Each Other Like Yin and Yang?26
Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies26
Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis25
Comparison of high‐dose dual therapy with bismuth‐containing quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: An open‐label, multicenter, randomized controlled trial25
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn25
Systematic review and meta‐analysis of the correlation between bispectral index (BIS) and clinical sedation scales: Toward defining the role of BIS in critically ill patients22
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline21
Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID‐1921
Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic review20
Scoping review of augmented renal clearance in critically ill pediatric patients19
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy18
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists18
A systematic review of the drug–drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies18
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections17
Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinic17
Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists17
Risk of Venous Thromboembolism Associated With Tofacitinib and Baricitinib: A Systematic Review and Indirect Meta‐Analysis17
Use of direct‐acting oral anticoagulants in solid organ transplantation: A systematic review16
Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipients16
Cisplatin‐induced nephrotoxicity in an outpatient setting16
Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta‐analysis16
Comparison of Bayesian‐derived and first‐order analytic equations for calculation of vancomycin area under the curve15
Use of psychiatric medication by college students: A decade of data15
Physiologically based pharmacokinetic modeling of tramadol to inform dose adjustment and drug‐drug interactions according to CYP2D6 phenotypes15
Prophylactic norepinephrine infusion for postspinal anesthesia hypotension in patients undergoing cesarean section: A randomized, controlled, dose‐finding trial15
Anticholinergic medication burden and cognitive function in participants of the ASPREE study15
Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design15
Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: A cross‐sectional study15
Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients14
Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID‐19): A systematic review14
Alopecia signals associated with calcitonin gene‐related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study14
The impact of statin use prior to intensive care unit admission on critically ill patients with sepsis14
Multi‐center retrospective study evaluating the efficacy and safety of apixaban versus warfarin for treatment of venous thromboembolism in patients with severe obesity13
Optimization of Vancomycin Dosing Regimen in Cancer Patients using Pharmacokinetic/Pharmacodynamic Modeling13
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review13
Myocardial infarction associated with erenumab: A case report13
Comprehensive guidance for antibiotic dosing in obese adults: 2022 update13
Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections12
Achievement of goal anti‐Xa activity with weight‐based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients12
Tebipenem pivoxil hydrobromide—No PICC, no problem!12
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with 12
Glucagon: Its evolving role in the management of hypoglycemia12
Systematic review of drug–drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management12
Omega‐3 fatty acids for the prevention of atherosclerotic cardiovascular disease12
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation12
The association between urate‐lowering therapies and treatment‐related adverse events, liver damage, and major adverse cardiovascular events (MACE): A network meta‐analysis of randomized trials12
A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the12
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–201612
Pneumococcal vaccination—A literature review and practice guideline update12
The role of inflammation in the pathogenesis and treatment of arrhythmias11
Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity11
Methadone‐associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program11
Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease11
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care11
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and Inter11
Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series11
Management of noncytotoxic extravasation injuries: A focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline10
A systematic review of clozapine‐associated inflammation and related monitoring10
Precision‐based approaches to delirium in critical illness: A narrative review10
Hydroxychloroquine in Hospitalized Patients with COVID‐19: Real‐World Experience Assessing Mortality10
Response to intravenous racemic ketamine after switch from intranasal (S)‐ketamine on symptoms of treatment‐resistant depression and post‐traumatic stress disorder in Veterans: A retrospective case se10
Systematic literature review of insulin dose adjustments when initiating hemodialysis or peritoneal dialysis10
Reduced alternative insulin dosing in hyperkalemia: A meta‐analysis of effects on hypoglycemia and potassium reduction10
Safety and efficacy of a platelet glycoprotein Ib inhibitor for patients with non‐ST segment elevation myocardial infarction: A phase Ib/IIa study10
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial10
Examining the clinical impact of rapid multiplex polymerase chain reaction‐based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration9
TheMPRINTHub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics9
Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction9
Factors influencing antibiotic duration in culture‐negative neonatal early‐onset sepsis9
Using Child‐Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model‐based Analysis9
Pharmacogenetics ofP2Y12receptor inhibitors9
Immunosuppression considerations in simultaneous organ transplant9
Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy9
Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m29
First‐Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area‐Under‐the‐Curve Target Attainment in Critically Ill Patients9
Efficacy of inactivated vaccines in patients treated with immunosuppressive drug therapy8
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures8
Precision fluid and vasoactive drug therapy for critically ill patients8
Scoping review of rational polytherapy in patients with drug‐resistant epilepsy8
Anticoagulation strategies in patients with extracorporeal membrane oxygenation: A network meta‐analysis and systematic review8
A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision8
The safety of rapid infusion levetiracetam: A systematic review8
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study8
Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy8
Restrictive resuscitation in patients with sepsis and mortality: A systematic review and meta‐analysis with trial sequential analysis8
Successful prolonged treatment of a carbapenem‐resistant Acinetobacter baumannii hip infection with cefiderocol: A case report7
Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies7
Efficacy of risdiplam in spinal muscular atrophy: A systematic review and meta‐analysis7
Lack of drug interaction between levetiracetam and high‐dose methotrexate in patients with lymphoma7
Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype‐Based Dosing Algorithms7
Low‐dose versus standard‐dose four‐factor prothrombin complex concentrate for factor‐Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage7
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired‐hepatic function7
Tacrolimus time in therapeutic range and long‐term outcomes in heart transplant recipients7
Advances in personalized medicine and noninvasive diagnostics in solid organ transplantation7
Pharmacotherapy for durable left ventricular assist devices7
Enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in renally impaired ICU patients7
A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults7
Machine learning to predict vasopressin responsiveness in patients with septic shock7
Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis7
Effects of GLP‐1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta‐analysis7
Patient risk factors for opioid‐related adverse drug events in hospitalized patients: A systematic review7
Comparative effectiveness of early‐targeted use of fidaxomicin versus oral vancomycin among hospitalized veterans’ affairs patients with infections due to Clostridioides difficile6
Role of the gut microbiome in cardiovascular drug response: The potential for clinical application6
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients6
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review6
Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration6
The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysis6
New ways of using old antibiotics in pediatrics: Focus on fosfomycin6
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect6
Advances in the treatment of transthyretin cardiac amyloidosis: Current and emerging therapies6
Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction6
TT genotype of the MMP‐9‐1562C/T polymorphism may be a risk factor for thrombolytic therapy‐induced hemorrhagic complications after acute ischemic stroke6
Administration of rabies immunoglobulin: Improving evidence‐based guidance for wound infiltration6
0.04721999168396